Zimmer Biomet Holdings Total Liabilities and Share Holders Equity 2010-2024 | ZBH
Zimmer Biomet Holdings total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- Zimmer Biomet Holdings total liabilities and share holders equity for the quarter ending December 31, 2024 was $21.365B, a 0.61% decline year-over-year.
- Zimmer Biomet Holdings total liabilities and share holders equity for 2024 was $21.365B, a 0.61% decline from 2023.
- Zimmer Biomet Holdings total liabilities and share holders equity for 2023 was $21.497B, a 2.05% increase from 2022.
- Zimmer Biomet Holdings total liabilities and share holders equity for 2022 was $21.066B, a 10.19% decline from 2021.
| Zimmer Biomet Holdings Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024 | $21,365 |
| 2023 | $21,497 |
| 2022 | $21,066 |
| 2021 | $23,456 |
| 2020 | $24,418 |
| 2019 | $24,639 |
| 2018 | $24,127 |
| 2017 | $26,014 |
| 2016 | $26,684 |
| 2015 | $27,161 |
| 2014 | $9,658 |
| 2013 | $9,581 |
| 2012 | $9,012 |
| 2011 | $8,515 |
| 2010 | $8,000 |
| 2009 | $7,786 |
| Zimmer Biomet Holdings Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024-12-31 | $21,365 |
| 2024-09-30 | $21,720 |
| 2024-06-30 | $21,520 |
| 2024-03-31 | $21,452 |
| 2023-12-31 | $21,497 |
| 2023-09-30 | $21,217 |
| 2023-06-30 | $21,294 |
| 2023-03-31 | $21,244 |
| 2022-12-31 | $21,066 |
| 2022-09-30 | $21,333 |
| 2022-06-30 | $21,453 |
| 2022-03-31 | $21,618 |
| 2021-12-31 | $23,456 |
| 2021-09-30 | $24,009 |
| 2021-06-30 | $24,223 |
| 2021-03-31 | $24,027 |
| 2020-12-31 | $24,418 |
| 2020-09-30 | $24,026 |
| 2020-06-30 | $23,648 |
| 2020-03-31 | $25,513 |
| 2019-12-31 | $24,639 |
| 2019-09-30 | $24,315 |
| 2019-06-30 | $24,206 |
| 2019-03-31 | $24,289 |
| 2018-12-31 | $24,127 |
| 2018-09-30 | $25,382 |
| 2018-06-30 | $25,491 |
| 2018-03-31 | $27,181 |
| 2017-12-31 | $26,014 |
| 2017-09-30 | $26,418 |
| 2017-06-30 | $26,459 |
| 2017-03-31 | $26,988 |
| 2016-12-31 | $26,684 |
| 2016-09-30 | $27,037 |
| 2016-06-30 | $25,971 |
| 2016-03-31 | $26,297 |
| 2015-12-31 | $27,161 |
| 2015-09-30 | $26,689 |
| 2015-06-30 | $27,204 |
| 2015-03-31 | $17,190 |
| 2014-12-31 | $9,658 |
| 2014-09-30 | $9,671 |
| 2014-06-30 | $9,638 |
| 2014-03-31 | $9,380 |
| 2013-12-31 | $9,581 |
| 2013-09-30 | $9,357 |
| 2013-06-30 | $9,097 |
| 2013-03-31 | $8,745 |
| 2012-12-31 | $9,012 |
| 2012-09-30 | $8,784 |
| 2012-06-30 | $8,617 |
| 2012-03-31 | $8,604 |
| 2011-12-31 | $8,515 |
| 2011-09-30 | $8,199 |
| 2011-06-30 | $8,249 |
| 2011-03-31 | $8,118 |
| 2010-12-31 | $8,000 |
| 2010-09-30 | $8,004 |
| 2010-06-30 | $7,827 |
| 2010-03-31 | $7,822 |
| 2009-12-31 | $7,786 |
| 2009-09-30 | $7,648 |
| 2009-06-30 | $7,462 |
| 2009-03-31 | $7,232 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.837B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.816B | 27.87 |
| Boston Scientific (BSX) | United States | $152.176B | 38.10 |
| Stryker (SYK) | United States | $145.393B | 30.40 |
| EssilorLuxottica (ESLOY) | France | $127.544B | 0.00 |
| Medtronic (MDT) | Ireland | $107.067B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.941B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.416B | 27.54 |
| ResMed (RMD) | United States | $35.930B | 26.99 |
| GE HealthCare Technologies (GEHC) | United States | $31.992B | 15.19 |
| Agilent Technologies (A) | United States | $30.486B | 20.14 |
| Terumo (TRUMY) | Japan | $28.205B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.066B | 16.58 |
| Insulet (PODD) | United States | $21.859B | 85.82 |
| Baxter (BAX) | United States | $15.857B | 11.84 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.412B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.686B | 22.60 |
| Lantheus Holdings (LNTH) | United States | $5.655B | 14.27 |
| Prestige Consumer Healthcare (PBH) | United States | $4.325B | 19.27 |
| Perrigo (PRGO) | Ireland | $3.713B | 9.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.426B | 14.92 |
| ICU Medical (ICUI) | United States | $3.404B | 25.10 |
| Envista Holdings (NVST) | United States | $2.981B | 24.77 |
| QuidelOrtho (QDEL) | United States | $2.458B | 16.90 |
| GN Store Nord (GNNDY) | Denmark | $2.075B | 17.18 |
| LeMaitre Vascular (LMAT) | United States | $1.813B | 40.53 |
| AtriCure (ATRC) | United States | $1.534B | 0.00 |
| Neogen (NEOG) | United States | $1.296B | 16.58 |
| Green Thumb Industries (GTBIF) | United States | $1.173B | 26.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.164B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.156B | 11.75 |
| BioLife Solutions (BLFS) | United States | $1.106B | 0.00 |
| InMode (INMD) | Israel | $1.005B | 9.20 |
| Phibro Animal Health (PAHC) | United States | $0.910B | 11.64 |
| Evolus (EOLS) | United States | $0.632B | 0.00 |
| CeriBell (CBLL) | United States | $0.577B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.557B | 0.00 |
| Owens & Minor (OMI) | United States | $0.542B | 4.49 |
| Valneva SE (VALN) | France | $0.541B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.504B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.431B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 0.00 |
| Omeros (OMER) | United States | $0.360B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.358B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.290B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.283B | 10.42 |
| Aurora Cannabis (ACB) | Canada | $0.273B | 48.50 |
| Sanuwave Health (SNWV) | United States | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.250B | 21.07 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.09 |
| Canopy Growth (CGC) | Canada | $0.241B | 0.00 |
| Biote (BTMD) | United States | $0.219B | 6.15 |
| Quanterix (QTRX) | United States | $0.205B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.18 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| TriSalus Life Sciences (TLSI) | United States | $0.162B | 0.00 |
| Organigram Global (OGI) | Canada | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 18.16 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.103B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| MacroGenics (MGNX) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| Fonar (FONR) | United States | $0.077B | 10.77 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| United Health Products (UEEC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.00 |
| United-Guardian (UG) | United States | $0.037B | 12.79 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |